We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00166179
First Posted: September 14, 2005
Last Update Posted: September 26, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Randolph E Patterson, Emory University
  Purpose
The purpose of this study is to compare cardiac MRI with positron emission tomography (PET) with fluorodeoxyglucose (FDG) to determine if cardiac MRI images are as good as, or better, than PET with FDG.

Condition
Coronary Artery Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI

Resource links provided by NLM:


Further study details as provided by Randolph E Patterson, Emory University:

Primary Outcome Measures:
  • Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI [ Time Frame: time of initial scans ]

Secondary Outcome Measures:
  • Compare size of regions of viable and non viable myocardium as % left ventricle by MRI vs. PET [ Time Frame: at time of initial scans ]

Enrollment: 57
Study Start Date: November 2003
Study Completion Date: October 2006
Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 95 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Age > 25 yrs, mean + SD = 60.3 + 10.2, 83% male, are patients referred by cardiologist or cardiac surgeon for assessment of myocardial viability by PET FDG.
Criteria

Inclusion Criteria:

  • PET-FDG ordered to assess myocardial viability

Exclusion Criteria:

  • Contraindicated for MRI
  • Pregnant
  • Age <25 yrs
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00166179


Locations
United States, Georgia
Crawford Long Hospital
Atlanta, Georgia, United States, 30308
Sponsors and Collaborators
Emory University
Investigators
Principal Investigator: Randolph Patterson, MD Staff
  More Information

Responsible Party: Randolph E Patterson, Professor, Emory University
ClinicalTrials.gov Identifier: NCT00166179     History of Changes
Other Study ID Numbers: IRB00000292
6-56550 ( Other Identifier: Other )
First Submitted: September 13, 2005
First Posted: September 14, 2005
Last Update Posted: September 26, 2014
Last Verified: September 2014

Keywords provided by Randolph E Patterson, Emory University:
CAD

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases


To Top